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Summary
Themetabolic demands and synthetic capacity of the lactatingmammary gland exceed that of any other tissue, thereby pro-
viding a useful paradigm for understanding the developmental regulation of cellular metabolism. By evaluating mice bearing
targeted deletions in Akt1 or Akt2, we demonstrate that Akt1 is specifically required for lactating mice to synthesize suffi-
cient quantities of milk to support their offspring. Whereas cellular proliferation, differentiation, and apoptosis are unaf-
fected, loss of Akt1 disrupts the coordinate regulation of metabolic pathways that normally occurs at the onset of lactation.
This results in a failure to upregulate glucose uptake, Glut1 surface localization, lipid synthesis, and multiple lipogenic en-
zymes, as well as a failure to downregulate lipid catabolic enzymes. These findings demonstrate that Akt1 is required in an
isoform-specificmanner for orchestratingmany of the developmental changes in cellularmetabolism that occur at the onset
of lactation and establish a role for Akt1 in glucose metabolism.Introduction
The developmental program that prepares the mammary gland
for lactation is among the most critical and highly conserved in
mammals, as the provision of nutritional support is essential
for the survival of offspring from this class of vertebrates. Lacta-
tion represents the terminally differentiated state of the mam-
mary gland and is the culmination of an orchestrated series of
developmental events occurring during pregnancy and early
lactation that involve mammary epithelial proliferation, differen-
tiation, and secretory activation.
Although mammary epithelial cells do not proliferate during
lactation, other than in the initial 24 hr, the metabolic demands
and synthetic capacity of the lactating mammary gland exceed
that of any other tissue. During a typical 21-day course of lacta-
tion, a lactatingmouse will produce its entire body weight in lipid
as well as three times its total body weight in milk, whose prin-
cipal constituents are lipid (30%), protein (15%), and lactose
(3%) (Schwertfeger et al., 2003). To accomplish this, two distinct
developmental programs must be executed: first, alveolar epi-
thelial cells must proliferate and differentiate to form lobuloal-
veolar structures that will ultimately serve as the site of milk syn-
thesis during lactation, and second, during the transition from
pregnancy to lactation, mammary epithelial cells must coordi-
nately upregulate multiple biosynthetic pathways—as well as
downregulate catabolic pathways—in order to have the meta-
bolic capacity to synthesize large quantities of milk. As such,
the lactating mammary gland provides an ideal setting in whichCELL METABOLISM 4, 475–490, DECEMBER 2006 ª2006 ELSEVIER INto study the developmental regulation of cellular metabolism
under highly anabolic, yet nonproliferative, conditions.
Prior analyses of protein kinase expression patterns during
mammary gland development revealed that expression of the
serine-threonine kinase Akt1 is markedly upregulated during
pregnancy and lactation, suggesting a potential developmental
role for this kinase (Chodosh et al., 2000). In addition, constitu-
tive activation of Akt1 in themammary glands of transgenicmice
induces precocious lipid accumulation during pregnancy, sug-
gesting that Akt upregulation during pregnancy and lactation
may help meet the increased synthetic demand for lipid
(Schwertfeger et al., 2003). Nevertheless, while these experi-
ments suggest a role for Akt in the developmental regulation
of milk synthesis and metabolism in the lactating mammary
gland, they do not address whether Akt is required for these
processes, nor do they determine which Akt isoforms may be
important.
Mice bearing targeted deletions in Akt1, Akt2, or Akt3 have
been used to evaluate the physiologic roles of Akt family mem-
bers (Chen et al., 2001, 2004; Cho et al., 2001a, 2001b; Easton
et al., 2005; Garofalo et al., 2003; Tschopp et al., 2005) and have
identified redundant as well as specific functions for Akt iso-
forms. For example, among the three Akt family members,
only deletion of Akt2 has thus far been shown to result in im-
paired metabolism in mice. Akt22/2 mice display a diabetes
mellitus-like syndrome characterized by hyperglycemia and hy-
perinsulinemia (Cho et al., 2001a; Garofalo et al., 2003). In con-
trast, glucose homeostasis is normal inmice deficient for Akt1 orC. DOI 10.1016/j.cmet.2006.10.011 475
A R T I C L EAkt3 (Chen et al., 2001; Cho et al., 2001b; Easton et al., 2005;
Tschopp et al., 2005). Akt1 null mice instead display mild growth
retardation and increased thymic and testicular apoptosis,
whereas Akt3 null mice display reduced postnatal brain growth
(Chen et al., 2001; Cho et al., 2001a; Garofalo et al., 2003).
Akt1 has, however, been implicated in the control of cellular
metabolism in other contexts (Plas and Thompson, 2005).
Whereas Akt2 regulates insulin-mediated Glut4 translocation
in liver, skeletal muscle, and fat, Glut1 expression is ubiquitous
and is upregulated in response to growth factor and oncogene-
mediated activation of Akt (Barnes et al., 2005; Rathmell et al.,
2003). Overexpression of Akt1 in hematopoietic cells increases
Glut1 translocation and enhances phosphorylation of glucose
by hexokinase, the rate-limiting step of glycolysis, by promot-
ing translocation of this enzyme to the mitochondrial outer
membrane (Gottlob et al., 2001; Plas et al., 2001). In addition
to glucose metabolism, Akt1 has also been implicated in regu-
lating protein synthesis (Dan et al., 2002; Inoki et al., 2002; Man-
ning et al., 2002; Potter et al., 2002) as well as lipid synthesis
(Berwick et al., 2002; Kohn et al., 1996; Magun et al., 1996;
Schwertfeger et al., 2003).
To investigate the developmental roles played by specific Akt
isoforms in the response to metabolic stress, we evaluated the
ability of mice bearing targeted deletions in Akt1 or Akt2 to lac-
tate. Our studies demonstrate that Akt1 is required—in an iso-
form-specific manner—for orchestrating many of the dramatic
developmental changes in metabolism that occur in the mam-
mary gland at the transition from pregnancy to lactation. Specif-
ically, the mammary glands of Akt1 null mice fail to upregulate
glucose uptake and trapping, membrane localization of Glut1,
lipid synthesis, activation of ATP-citrate lyase, and expression
of stearoyl-CoA desaturases. In addition, Akt1 loss results in
the inappropriate derepression of enzymes involved in the b-ox-
idation of fatty acids. Thus, in the absence of Akt1, the coordi-
nate developmental regulation of multiple synthetic pathways
that is essential for the successful transition to the lactating state
fails to occur. As a result, nursing mothers are unable to support
the growth or survival of their offspring. Together, these studies
identify an isoform-specific requirement for Akt1 in the develop-
mental regulation of cellular metabolism and establish a role for
Akt1 both in glucose metabolism and as a central regulator of
the response to metabolic stress.
Results
Isoform-specific regulation of Akt expression during
mammary gland development
To begin evaluating the contributions of specific Akt isoforms to
the metabolic response of the mammary gland to the synthetic
demands of lactation, mRNA expression patterns of Akt1,
Akt2, and Akt3 and were analyzed by northern hybridization at
12 time points encompassingmammary gland development. Di-
lutional effects of milk protein gene expression, as exemplified
by the apparent decrease in b-actin mRNA levels during late
pregnancy and lactation (Figure 1A), were accounted for by nor-
malizing Akt gene expression to that of b-actin (Figure 1B). This
analysis revealed that Akt1 mRNA levels in the mammary gland
increased during late pregnancy and lactation and then returned
to baseline during early postlactational involution (Figures 1A
and 1B; Chodosh et al., 2000). In contrast, expression levels of
Akt2 and Akt3 decreased during early pregnancy and remained476low throughout pregnancy, lactation, and early involution before
returning to baseline late in postlactational involution.
Immunoblotting with antibodies specific for Akt1 or Akt2 con-
firmed the distinct developmental expression patterns of these
isoforms. Akt1 protein expression increased during pregnancy
and lactation, whereas Akt2 expression decreased during these
same stages of development (Figure 1C). In agreement with pre-
vious reports, total Akt and the level of activated phospho-
Akt(Ser473) decreased at the onset of postlactational involution
concomitant with the onset of widespread epithelial apoptosis
(Figure 1C; Schwertfeger et al., 2001). Notably, homozygous de-
letion of Akt1 resulted in a marked decrease in total Akt protein
content in lactating mammary tissue, whereas homozygous
deletion of Akt2 did not (Figure 1C).
Western analysis of epithelial and adipose tissue isolated from
5-week-old nulliparous mice was performed to explore whether
the differences in the developmental expression profiles of Akt1
and Akt2 in the mammary gland may reflect differences in their
localization within the mammary gland. These experiments re-
vealed that Akt1 and Akt2 are each expressed within both the
epithelial and stromal compartments of the mammary gland,
and with a similar ratio of expression between the two compart-
ments (Figure 1D). These findings demonstrate that the appar-
ent differential developmental regulation of Akt1 and Akt2 ex-
pression in the mammary gland is not simply a consequence
of their expression in different cellular compartments or of their
exclusive expression within a cellular compartment that ex-
pands or contracts during mammary development. Rather, our
results suggest that Akt1 and Akt2 are expressed within the
same cell types in the virgin mammary gland and at similar rela-
tive ratios between the epithelial and stromal compartments.
Together, the distinct developmental expression profiles of Akt
family members in the mammary gland raise the possibility
that these kinases play isoform-specific functions in this tissue
during pregnancy and lactation.
Akt1, but not Akt2, is required for pup growth
and survival during lactation
To evaluate the roles played by specific Akt isoforms during
mammary gland development, lactating mice bearing targeted
deletions in either Akt1 or Akt2 were analyzed for their ability
to support nursing litters of pups. As early as postpartum day
2, pups nursed by Akt12/2 mothers weighed significantly less
than those nursed by Akt1+/+ or Akt1+/2 mothers (Figure 2A).
This difference became more exaggerated during the postpar-
tum period. By 9 days postpartum, the average weight of
pups nursed by Akt12/2 mice was two-thirds that of pups
nursed by Akt1+/+ mice (Figure 2A). In contrast, pups born to
Akt22/2 mice did not exhibit any impairment in weight gain.
In addition to the growth retardation observed in pups born to
Akt12/2 females, these pups also exhibited increased mortality.
By 9 days postpartum, 25% of pups born to Akt12/2 females
had died, compared to the less than 2% mortality of pups
born to Akt1+/+, Akt1+/2, or Akt22/2 females (Figure 2B). The re-
duced growth and viability of litters nursed by Akt12/2 females
was not due to abnormal maternal behavior since Akt12/2
females built nests and suckled their pups appropriately. Thus,
maternal Akt1 is specifically required for the survival of offspring
during nursing.
Notably, the observed defect in pup growth and viability in
Akt12/2 mice was dependent upon the genotype of the motherCELL METABOLISM : DECEMBER 2006
Akt1 regulates metabolism during developmentFigure 1. Akt isoforms are differentially regulated during mammary gland development
A) Northern analysis of Akt isoform expression during mammary gland development. Independent RNA samples isolated from mammary glands of female FVB mice at 12
developmental time points were electrophoresed on replicate blots and analyzed by northern hybridization using cDNA probes from the 30 untranslated regions of Akt1,
Akt2, Akt3, and b-actin. The decreased b-actin signals at D18.5 of pregnancy and D9 of lactation reflect dilution by the abundant expression of milk protein genes at these
developmental stages.
B) Phosphorimager quantification of Akt1, Akt2, and Akt3 expression from northern blots in (A). Bars depict the signal intensity for each Akt isoform normalized to b-actin.
C) Immunoblot analysis of Akt isoform protein expression during mammary gland development. Replicate blots were probed with antibodies specific for Akt1, Akt2, phos-
pho-Akt(Ser473), pan-Akt, and b-tubulin. Lysates from lactating Akt12/2 and Akt22/2 mice are included as controls for antibody specificity.
D) Immunoblot analyses of epithelial and stromal tissue isolated from the mammary glands of 5-week-old mice demonstrating expression of Akt1, Akt2, and cellular
markers specific for epithelial and stromal compartments of the mammary gland. The location of a nonspecific band detected by the anti-Akt1 antibody in cultured adipose
tissue is indicated by an arrow.rather than the genotype of the pups. Wild-type pups born
to wild-type mice but fostered to Akt12/2 mice at the time of
parturition exhibited reduced growth, whereas pups born to
Akt12/2 mice grew normally when nursed by wild-type mice
(Figure 2C). These observations indicate that Akt1, but not
Akt2, is required for lactating mice to support the growth and
survival of their litters.
Milk secretion is impaired in Akt12/2 mice
Pups nursed by Akt12/2 mice were found to have less milk in
their stomachs, suggesting that their increased mortality and
growth retardation was due to an inability of Akt12/2 mothersCELL METABOLISM : DECEMBER 2006to secrete normal amounts of milk. To address this directly,
milk was collected from lactating mice following administration
of oxytocin to stimulate milk release. Lactating Akt12/2 mice
displayed a 4-fold reduction in oxytocin-stimulated milk secre-
tion compared to Akt1+/+ mice (p = 0.0002) (Figure 2D). In con-
trast, oxytocin-stimulated milk secretion was normal in Akt22/2
mice (Figure 2D). These results demonstrate an isoform-specific
requirement for Akt1 in the mammary gland for the secretion of
normal amounts of milk during lactation.
Western analysis using a polyclonal antibody raised against
milk proteins demonstrated that the milk protein composi-
tions of milk collected from lactating Akt1+/+, Akt1+/2, and477
A R T I C L EFigure 2. Increased mortality and reduced growth of pups nursed by Akt12/2 females is associated with decreased amounts of milk of normal composition
A) Analysis of postpartum weight gain in pups nursed by Akt12/2 and Akt22/2 females. Graph depicts average daily pup weights for litters born to mice of the following
genotypes:Akt1+/+ (n = 9),Akt1+/2 (n = 17),Akt12/2 (n = 10), andAkt22/2 (n = 12).Akt12/2 versusAkt1+/+: p < 0.0007 at time points indicated by asterisk. Error bars in (A), (B),
(D), and (F) represent SEM.
B) Pup mortality in litters nursed by mice lacking Akt1 or Akt2. Pup mortality was determined for litters from female Akt1+/+ (n = 10), Akt1+/2 (n = 17), Akt12/2 (n = 10), and
Akt22/2 (n = 12) mice as the percentage of litters that died within the first 9 days postpartum. Akt12/2 versus Akt1+/+: p = 0.026; Akt12/2 versus Akt1+/2: p = 0.003.
C)Reducedweight gain in pups nursed byAkt12/2mice is independent of pup genotype or the genotype of their birth mother. On the day of parturition, litters from Akt12/2
females were exchangedwith those ofAkt1+/+ females. Pupweights weremeasured postpartum and compared to those for control litters of mice that were not exchanged.
Pup growth is shown for representative litters.
D)Milk secretion following oxytocin stimulation. The volume of milk collected from number threemammary glands following oxytocin stimulation was compared for Akt1+/+
(n = 17), Akt1+/2 (n = 11), Akt12/2 (n = 9), and Akt22/2 (n = 5) mice at day 9 of lactation. Akt12/2 versus Akt1+/+, Akt12/2 versus Akt1+/2, Akt12/2 versus Akt22/2: p <0.001.
E)Milk protein analysis. Equal volumes of milk collected at day 9 of lactation from Akt1+/+ (n = 5), Akt1+/2 (n = 5), and Akt12/2 (n = 5) mice were analyzed by immunoblotting
using a polyclonal antibody raised against milk proteins.
F) Milk fat analysis. The percentage of lipid by volume was measured for milk samples collected at day 9 of lactation from Akt1+/+ (n = 5) and Akt12/2 (n = 5) mice.478 CELL METABOLISM : DECEMBER 2006
Akt1 regulates metabolism during developmentFigure 3. Normal lobuloalveolar development but
reduced milk secretion in mammary glands of
Akt12/2 mice
A) Carmine-stained whole-mounted mammary
glands from Akt1+/+ and Akt12/2 mice at days 12.5
and 18.5 of pregnancy. 163 magnification.
B)Hematoxylin-and-eosin-stained sections of mam-
mary glands from Akt1+/+ and Akt12/2 mice at days
12.5 and 18.5 of pregnancy and days 2 and 9 of lac-
tation showing decreased distention of mammary
ducts and alveoli in Akt12/2 mice. 2003 magnifica-
tion.
C)Hematoxylin-and-eosin-stained sections of mam-
mary glands from Akt2+/+ and Akt22/2 mice at day
18.5 of pregnancy and day 9 of lactation. 2003mag-
nification. Results are representative of sections
from at least three animals per group.
D)Quantification of epithelial nuclei at day 9 of lacta-
tion in the mammary glands of Akt1+/+ and Akt12/2
mice. For (D) and (E), the mean of five fields of view
from each of threemice per genotype is shown. Error
bars represent SEM.
E) Quantification of the number of alveoli at day 9 of
lactation in the mammary glands of Akt1+/+ and
Akt12/2 mice.Akt12/2 mice were indistinguishable (Figure 2E). Similarly, the
lipid content of milk samples did not differ between Akt1+/+ and
Akt12/2 mice (Figure 2F). Together, these data suggest that,
while total milk production is decreased in Akt12/2 mice, the
milk that is produced has a normal composition.
Deletion of Akt1 results in a functional rather than
structural defect in the mammary gland during
pregnancy and lactation
Milk production during lactation is preceded by lobuloalveolar
development during pregnancy. A central feature of lobuloal-
veolar development is the massive expansion of the mammary
epithelial compartment via cellular proliferation that gives rise
to increased branching of mammary ducts and formation of nu-
merous alveolar secretory units (Borst and Mahoney, 1982).
Since Akt is known to promote cellular proliferation and survival,
we wished to determine whether the defect observed in milk
production in lactating Akt12/2 mice resulted from a defect in
lobuloalveolar development.
Analysis of carmine-stained whole mounts of mammary
glands harvested frommid- to late-term pregnant mice (postco-
ital days 12.5 and 18.5, respectively) revealed that the number
and organization of lobuloalveolar structures in Akt1+/+ andCELL METABOLISM : DECEMBER 2006Akt12/2 mice were comparable (Figure 3A). Similarly, histologi-
cal sections of mammary glands from Akt1+/+ and Akt12/2mice
were indistinguishable at day 12.5 of pregnancy, as were the
numbers of epithelial cells present in mammary sections from
Akt1+/+ and Akt12/2 mice at days 12.5 and 18.5 of pregnancy
(Figure 3B and data not shown). Consistent with this, functional
evaluation of the mammary glands of Akt1+/+ and Akt12/2 mice
during pregnancy and lactation by BrdU incorporation and
TUNEL incorporation revealed indistinguishable rates of prolif-
eration and apoptosis, respectively (data not shown).
As predicted based upon the unperturbed cellular dynamics
of lobuloalveolar development in Akt12/2 mice during preg-
nancy, no differences were observed in the number of epithelial
cells per alveolus or the number of alveoli present in mammary
glands of Akt1+/+ and Akt12/2mice at day 9 of lactation (Figures
3B, 3D, and 3E). However, analysis of histological sections re-
vealed that alveoli inAkt12/2miceweremarkedly less distended
with milk than in Akt1+/+ littermates at day 18.5 of pregnancy
(Figure 3B). This reduction in alveolar distention in Akt12/2
mammary glands persisted throughout lactation (Figure 3B). In
contrast, both the formation of lobuloalveolar structures and se-
cretion of milk into the ductal lumen were unaffected in Akt22/2
mice at day 18.5 of pregnancy and day 9 of lactation (Figure 3C).479
A R T I C L EFigure 4. Secretory differentiation occurs normally
in Akt12/2mice
A) Northern analysis of milk protein gene expression
inmammary glands fromAkt1+/+ andAkt12/2mice at
days 12.5 and 18.5 of pregnancy and day 9 of lacta-
tion showing the normal temporal expression of
b-casein, WAP, a-lactalbumin, and 3-casein. Cyto-
keratin 18 and 18S rRNA are included as controls
for epithelial content and RNA loading, respectively.
B) NKCC1 (red) and smooth muscle actin (SMA)
(green) immunofluorescence staining in wild-type
(WT) virgin and day 9 lactation mammary sections
from WT, Akt12/2, and Akt22/2 female mice. As ex-
pected, NKCC1 immunostaining, which is character-
istic of nonsecretory luminal mammary epithelial
cells, is observed in virgin but not lactatingmammary
glands. SMA staining identifies myoepithelial cells,
which are positioned outside of luminal cells. Con-
trols show staining reactions on WT virgin mammary
sections in which the primary antibodies against
SMA (top left) or NKCC1 (top center) were omitted.
Nuclei were counterstained with Hoechst 33258
(blue). 4003 magnification.
C) Npt2b (red) and E-cadherin (green) immunofluo-
rescence staining in WT virgin and lactating WT,
Akt12/2, and Akt22/2 mice. Nuclei were counter-
stained with Hoechst 33258 (blue). As expected,
the apical membranes of luminal mammary epithelial
cells from lactating mice stain positively for Npt2b,
a marker for secretory alveolar cells, whereas
Npt2b staining is absent in virgin tissue (top right).
Controls show staining reactions on lactating mam-
mary sections in which the primary antibodies
against E-cadherin (top left) or Npt2b (top center)
were omitted. 4003 magnification.Taken together, these observations strongly suggest that the
isoform-specific requirement for Akt1 during lactation is due to
a functional defect in milk production rather than a structural
defect in mammary gland development.
Secretory differentiation occurs normally inAkt12/2mice
We next considered whether the failure of Akt12/2 mice to se-
crete normal amounts of milk was due to a defect in mammary
epithelial differentiation. Secretory differentiation in the mam-
mary gland is marked by the sequential upregulation of early,
mid, and late milk protein genes (Rosen et al., 1999). Northern
analysis of mammary RNA from four time points during preg-480nancy and lactation demonstrated that expression of early
(b-casein), mid (whey acidic protein and a-lactalbumin), and
late (3-casein) epithelial differentiation markers was indistin-
guishable between Akt12/2 and Akt1+/+ mice (Figure 4A).
Similar to milk protein gene expression, developmental regu-
lation of the expression and localization of the solute trans-
porters NKCC1 and Npt2b has been used to identify defects
in mammary epithelial cell differentiation (Shillingford et al.,
2003). Consistent with previous reports, NKCC1 staining on
the basolateral surface of ductal epithelial cells was easily de-
tected in mammary sections from wild-type virgin mice
(Figure 4B). In contrast, NKCC1 staining was absent—asCELL METABOLISM : DECEMBER 2006
Akt1 regulates metabolism during developmentexpected—in sections from lactating Akt1+/+, Akt12/2, and
Akt22/2 mice (Figure 4B).
Conversely, while Npt2b staining was absent in epithelial cells
from nulliparous mammary glands, the apical membranes of se-
cretory alveoli in Akt1+/+ and Akt22/2 mice stained intensely for
Npt2b at day 9 of lactation as expected (Figure 4C; Shillingford
et al., 2003). Notably, despite the fact that secretory alveoli in
Akt12/2 mice were not distended with milk, expression of
Npt2b was appropriately upregulated during lactation and prop-
erly localized to the apical membrane in a manner similar to that
observed in wild-type mice (Figure 4C). As such, the proper de-
velopmental regulation and localization of Npt2b and NKCC1
observed in Akt12/2 mice, when considered together with
the appropriate temporal induction of milk protein gene expres-
sion, strongly suggests that the lactation defect observed in
Akt12/2mice is not due to a global defect in mammary epithelial
differentiation.
Loss of Akt1 results in decreased glucose uptake during
lactation
In addition to the regulation of milk protein gene transcription
and solute transporters, the differentiated function of the mam-
mary gland also requires the coordinate developmental upregu-
lation of multiple biosynthetic pathways during late pregnancy
and early lactation. In particular, the enormous energetic and
synthetic demands of lactation require high levels of glucose
transport to provide adequate substrate and energy to support
the synthesis of milk proteins, lactose, and lipids. Accordingly,
the developmental transition from pregnancy to lactation is
accompanied by marked increases in Glut1 expression and its
localization to the basal membrane of mammary epithelial cells
(Camps et al., 1994).
To determine whether the lactation defect in Akt12/2 mice
was associated with decreased glucose uptake, we evaluated
the expression and localization of Glut1 by immunofluores-
cence.Whereas Glut1 expression was abundant on the basolat-
eral surface of mammary epithelial cells from lactating Akt1+/+
and Akt22/2 mice, Glut1 was virtually absent from the cell sur-
face of lactating Akt12/2 mammary epithelial cells (Figure 5A).
Conversely, immunofluorescence analysis for Glut1 in mam-
mary sections from bitransgenic MMTV-rtTA/TetO-myrAkt1
(MTB/tAkt1) mice, in which expression of a constitutively acti-
vated allele of Akt1 was induced by doxycycline administration
for 96 hr (R.B.B. and L.A.C., unpublished data), demonstrated
a marked, acute increase in the expression and cell-surface
localization of Glut1 in response to Akt activation (Figure 5B).
Together, these data indicate that Akt1 is a critical regulator
of Glut1 expression and localization in the mammary gland
in vivo, which in turn suggests that Akt1 may regulate glucose
uptake in this developmental context.
To directly examine the rate of glucose uptake and capture in
lactating mammary glands in vivo, positron emission tomogra-
phy was used to evaluate the accumulation of [18F]fluorodeoxy-
glucose ([18F]FDG). In accordance with the dramatic increase in
metabolism that occurs during lactation, [18F]FDG uptake was
markedly elevated in the mammary glands of lactating com-
pared to nulliparous wild-type mice (Figure 5C). In contrast, no
increase in [18F]FDG uptake was evident in themammary glands
of lactating Akt12/2 mice (Figure 5C). Lactating Akt22/2 mice,
however, exhibited high levels of [18F]FDG uptake comparable
to those observed in lactating wild-type mice (Figure 5C). TheseCELL METABOLISM : DECEMBER 2006observations demonstrate that Akt1 is required in an isoform-
specific manner for the developmental-stage-specific increase
in glucose uptake and trapping that occurs in the mammary
gland at the onset of lactation.
Intraepithelial levels of lactose and milk proteins
are normal in lactating Akt12/2 mice
The above findings demonstrated that the inability of Akt1-defi-
cient mice to secrete normal amounts of milk during lactation is
accompanied by a failure to upregulate glucose uptake in the
mammary gland in a developmentally appropriate manner.
The marked increase in glucose delivery to mammary epithelial
cells that occurs at the onset of lactation is required to provide
adequate substrate and energy to support the synthesis of
milk proteins, lipids, and lactose. As the predominant carbohy-
drate in milk, lactose is one of the key osmotic regulators of milk
secretion. Indeed, homozygous deletion of the regulatory sub-
unit of lactose synthetase a-lactalbumin, whose expression is
rate limiting for lactose synthesis, results in the formation of
milk that is markedly reduced in volume and highly viscous
such that it cannot be removed from the mammary gland by
suckling pups (Stinnakre et al., 1994).
Arguing against such a mechanism for the impairment of lac-
tation in Akt12/2mice, however, the upregulation of a-lactalbu-
min expression at day 18.5 of pregnancywas unaffected byAkt1
deletion (Figure 4A). Additionally, staining of mammary sections
with the lactose-specific lectin ECA revealed similar levels of
lactose in lactating Akt12/2 and Akt1+/+ glands (Figure 6A).
Thus, despite decreased glucose uptake and trapping in lactat-
ing Akt12/2 mice, steady-state levels of the principal sugar
in milk—which is itself derived from glucose—were largely
unaffected by loss of Akt1.
As noted above, the temporal regulation of milk protein gene
expression during pregnancy was unaltered in Akt12/2 mice.
However, despite transcription of milk protein genes during
pregnancy, large-scale production of milk proteins does not oc-
cur until after parturition and requires the developmental upre-
gulation of protein synthetic pathways, such as those regulated
by mTOR. Since glucose represents a major source of energy in
the lactating cell, and since Akt functions upstreamofmTOR,we
considered the possibility that lactation failure in Akt12/2 mice
was due to defects in the developmental activation of the
mTOR pathway and milk protein synthesis.
In contrast to this expectation, levels of the Ser235/236-phos-
phorylated form of the mTOR downstream effector S6 were ap-
propriately upregulated in the mammary glands of Akt12/2mice
during lactation to levels indistinguishable from those in wild-
type mice (Figure 6B, compare nulliparous MTB and lactating
Akt1+/+ and Akt12/2 samples). These findings suggest that
mTOR activity is largely unaffected by the absence of Akt1.
Moreover, immunoblotting and immunofluorescence analyses
demonstrated normal levels of milk proteins in the mammary
gland and normal packaging of milk proteins into casein
micelles (Figures 6C and 6D). Consistent with this, electron mi-
croscopy of epithelial cells from lactating Akt1+/+ and Akt12/2
mice revealed comparable numbers of ribosomes that were
engaged appropriately on the endoplasmic reticulum (Figure 6E,
lower panels). In aggregate, these findings indicate that milk
protein synthesis—including the activation of the mTOR path-
way—as well as lactose synthesis are largely unaffected by
the deletion of Akt1.481
A R T I C L EFigure 5. Decreased glucose uptake in the mam-
mary glands of lactating Akt12/2 mice
A) Immunofluorescence analysis of Glut1 expression
during lactation. Mammary sections from virgin WT
(top left), lactating WT (top right), Akt12/2 (bottom
left), and Akt22/2 (bottom right) mice were immuno-
stained for Glut1 (green). Nuclei were counterstained
with Hoechst 33258 (blue). 4003 magnification.
B) Immunofluorescence analysis of Glut1 expression
in inducible Akt1 transgenic mice. Mammary sec-
tions from control MTB (left) and MTB/tAkt1 (right)
mice were immunostained for Glut1 (green). Nuclei
were counterstained with Hoechst 33258 (blue).
4003 magnification.
C) [18F]FDG uptake during mammary gland develop-
ment. Virgin and day 9 lactatingAkt1+/+,Akt12/2, and
Akt22/2 mice were administered [18F]FDG by tail-
vein injection 2 hr prior to positron emission tomog-
raphy (PET) scanning. Coronal and transverse im-
ages are shown for representative mice. Positions
of mammary glands are indicated by arrows. Normal
uptake in heart (H) and bladder (B) are indicated.Akt1 is required for the upregulation of lipid synthesis
in the lactating mammary gland
In addition to its requirement for protein and lactose synthesis,
glucose also provides both energy and substrate for lipid pro-
duction in the mammary gland. Indeed, lipid represents the
most abundant constituent in milk, as a lactating mouse pro-482duces its entire body weight in lipid while nursing a single litter.
Accordingly, the production of adequate amounts of lipid during
lactation constitutes the principal metabolic stress onmammary
epithelial cells. In turn, lipid is itself a critical dietary source of en-
ergy and substrate for rapidly growing offspring in the neonatal
period.CELL METABOLISM : DECEMBER 2006
Akt1 regulates metabolism during developmentFigure 6. Normal lactose and protein but decreased
lipid content in mammary epithelial cells from lactat-
ing Akt12/2 mice
A) Lactose-specific lectin staining of mammary epi-
thelial cells. Mammary sections from virgin Akt1+/+
mice (left) and day 9 lactating Akt1+/+ (center) and
Akt12/2 (right) mice stained for lactose using a Texas
red-labeled ECA lectin. Magnified areas are shown in
red boxes. Scale bars = 10 mm.
B)Western analysis of phospho-S6(Ser235/236) and
total S6 expression in mammary protein lysates from
lactating Akt1+/+ and Akt12/2 mice. Lysates from
MTB and doxycycline-induced MTB/tAkt1 mice are
shown as controls.
C) Western analysis of casein expression in mam-
mary glands of Akt1+/+ and Akt12/2 mice at day 9
of lactation. b-tubulin levels are shown as a loading
control.
D) Immunofluorescence analysis of casein micelles
in mammary glands of Akt1+/+ and Akt12/2 mice at
day 9 of lactation. Scale bars = 10 mm.
E) Electron microscopy of mammary gland sections
from lactating Akt1+/+ (left) and Akt12/2 (right) mice.
Lipid vesicles budding from the endoplasmic reticu-
lum are indicated by white arrows. m, mitochondria.
Top, middle, and bottom panels are at 50,0003,
100,0003, and 200,0003 magnification, respec-
tively.
F) Nile red staining of cytoplasmic lipid droplets in
mammary sections from lactating Akt1+/+ (left) and
Akt12/2 (right) mice. Magnified areas are shown in
white boxes. Lu, alveolar lumen. Scale bars = 10 mm.Since Akt has previously been implicated in the regulation of
fatty-acid synthesis (Gagnon et al., 1999; Porstmann et al.,
2005; Van de Sande et al., 2002), we sought to determine
whether the impaired production of milk observed in lactating
Akt12/2 mice was associated with a defect in lipid production.
Examination by electron microscopy of mammary sections from
lactating Akt1+/+ and Akt12/2 mice revealed numerous small
lipid vesicles budding from the endoplasmic reticulum of mam-
mary epithelial cells in lactating Akt1+/+mice, whereas few lipid-
containing vesicles were observed in lactating Akt12/2 mice
(Figure 6E). In contrast, equivalent numbers of ribosomes
and mitochondria were observed in cells from lactating Akt1+/+
and Akt12/2mice. Consistent with the reduction in budding lipid
vesicles observed by electron microscopy, visualization of
lipid by Nile red staining revealed markedly fewer intracellular
lipid droplets within epithelial cells from lactating Akt12/2 com-CELL METABOLISM : DECEMBER 2006pared to Akt1+/+ mice (Figure 6F). These data suggest that Akt1
is required for the developmental upregulation of lipid synthesis
in the lactating mammary gland.
Akt1 is required for the developmental regulation
of multiple lipid synthetic enzymes
To meet the demand for increased de novo lipid synthesis in the
lactating mammary gland, the activities of multiple lipogenic
enzymes are coordinately upregulated at the onset of lactation
both transcriptionally as well as through phosphorylation and
allosteric control (Barber et al., 1997). For example, microarray
analysis revealed marked increases in stearoyl-CoA desaturase
2 (Scd-2) mRNA expression as well as modest but statistically
significant increases in fatty-acid synthase (Fasn) and stearoyl-
CoA desaturase 1 (Scd-1) expression in wild-type mice at the
transition from pregnancy to lactation (Figure 7A).483
A R T I C L EFigure 7. Akt1 mediates developmental changes in the expression and activity of enzymes involved in lipid metabolism
Microarray (A, B, and F), quantitative RT-PCR (C andD), and western analysis (E) of regulatory changes in lipid synthetic and catabolic enzymes in the mammary gland are
shown.
A) Microarray analysis of mammary gene expression changes for enzymes involved in lipid metabolism that occur at the transition from pregnancy to lactation. Three
pooled RNA samples isolated from mammary glands of wild-type female FVB mice at day 18.5 of pregnancy and day 9 of lactation were hybridized to MGU74Av2 Affy-
metrix arrays. For (A), (B), and (F), graphs depict average signal intensities, and error bars represent SEM. Gene expression changes determined to be statistically signif-
icant by ChipStat (Master et al., 2005) are indicated by a #.
B) Microarray analysis of gene expression for lipogenic enzymes in mammary glands of Akt1+/+ and Akt12/2 mice at day 9 of lactation. Independent RNA samples from
three mice of each genotype were hybridized to MOE430A Affymetrix arrays.
C)Quantitative RT-PCR analysis of genes involved in lipid synthesis. cDNA generated from total RNA samples of Akt1+/+ (n = 7) and Akt12/2 (n = 5) mammary glands at day
9 of lactation were analyzed by quantitative PCR. For (C) and (D), average expression values normalized to Tbp6 SEM are shown. Significant differences in expression as
measured by Student’s t test (p < 0.05) are indicated by an asterisk (*).
D)Quantitative RT-PCR analyses of genes involved in lipid synthesis are shown for cDNA generated fromMTB (n = 4) andMTB/tAkt1 (n = 4) mice induced with doxycycline
for 4 days.
E)Western analysis of phospho-Acly and total Acly expression in mammary glands from Akt1+/+ and Akt12/2 mice at day 9 of lactation. b-tubulin is shown as a loading
control. Protein lysates from kidney and adipose tissue are also shown as negative and positive controls, respectively.
F)Microarray expression analysis for enzymes involved in b-oxidation of fatty acids in mammary glands of Akt1+/+ and Akt12/2mice at day 9 of lactation. Total RNA from
mammary glands of Akt1+/+ (n = 3) and Akt12/2 (n = 3) mice during lactation were analyzed by microarray as in (B).484 CELL METABOLISM : DECEMBER 2006
Akt1 regulates metabolism during developmentIn addition to the developmental upregulation of enzymes
required for fatty-acid synthesis, the transition from pregnancy
to lactation is also accompanied by the coordinate downregula-
tion of multiple catabolic enzymes involved in the mitochondrial
b-oxidation of fatty acids, including the acyl-coenzyme A dehy-
drogenases Acadm and Acadl, the Hadhb and Hadhsc subunits
of the mitochondrial trifunctional protein, and acetyl-coenzyme
A acyltransferase 2 (Acaa2) (Figure 7A). As such, the coordinate
developmental regulation of gene expression that occurs at the
onset of lactation promotes the net synthesis of lipid by upregu-
lating lipid synthetic enzymes while downregulating lipid cata-
bolic enzymes.
To explore the mechanism by which Akt1 deficiency results
in impaired lipid accumulation in the lactating mammary gland,
we performed a microarray expression screen in Akt12/2 and
Akt1+/+ mice to identify alterations in the expression of key
enzymes regulating fatty acid and triglyceride metabolism.
Consistent with the observed decrease in intracellular lipid
in Akt12/2 mammary epithelial cells, expression of stearoyl-
CoA desaturase 2 (Scd2) and stearoyl-CoA desaturase 3
(Scd3) were markedly decreased, and the b isoform of acetyl-
CoA carboxylase (Acacb) was modestly decreased in the mam-
mary glands of lactating Akt12/2mice (Figure 7B). Scd1 expres-
sion was unaffected by Akt1 deletion (Figure 7B). In contrast,
expression of diacylglycerol acyltransferase 2 (Dgat2), which
catalyzes the final step in the production of triacylglycerol,
was increased.
To confirm the above changes in gene expression, quantita-
tive RT-PCR was performed on RNA from the mammary glands
of lactating Akt1+/+ and Akt12/2 mice (Figure 7C). Consistent
with microarray results, lactating Akt1-deficient mice exhibited
marked decreases in Scd2 and Scd3 expression, a significant
increase inDgat2 expression, and a trend toward decreased ex-
pression of Acacb. Again, no change was observed for Scd1
expression (Figure 7C). Moreover, significant alterations in the
expression of Fasn and ATP-citrate lyase (Acly) were not de-
tected (Figures 7B and 7C), despite previous reports of their
transcriptional regulation by Akt in other cell types (Porstmann
et al., 2005; Van de Sande et al., 2002). These findings suggest
that Akt1 may play a role in the coordinate upregulation of lipid
synthetic enzymes at the onset of lactation and identify Scd2,
Scd3, and Dgat2 as transcriptional targets of Akt1.
To further evaluate a causal role for Akt1 in the transcriptional
regulation of enzymes involved in lipid biosynthesis, the effect of
acute Akt1 activation on the expression of these enzymes was
determined in vivo in the mammary glands of MTB/tAkt1 bi-
transgenic mice induced to express activated Akt1 by the
administration of doxycycline for 4 days. In vivo activation of
Akt1 in the mammary epithelium resulted in a 4-fold induction
of Scd2, a 40-fold induction of Scd3, and no induction of Scd1
(Figure 7D). Additionally, consistent with our observations in
Akt12/2 mice, expression of Dgat2 was reduced by more than
50% in the mammary glands of induced bitransgenic mice
(Figure 7D). Modest Akt1-induced increases in Acacb and
Fasn expression were also observed.
The robust, inverse changes in Scd2 and Scd3 expression
that occur in response to Akt1 loss versus Akt1 activation in
the mammary gland suggest that Akt1 may play a relatively
direct role in regulating stearoyl-CoA desaturase expression,
as is further implied by the rapidity with which Scd expression
is induced following Akt1 induction in MTB/tAkt1 mice. GivenCELL METABOLISM : DECEMBER 2006that Scd mRNA levels are the main determinant of Scd activity
in the mammary gland (Singh et al., 2004) and that Scd activity
correlateswith a cell’s capacity for triglyceride synthesis (Listen-
berger et al., 2003), we conclude that Akt1-mediated upregula-
tion of Scd expression may constitute an important mechanism
for upregulating triglyceride synthesis during the transition from
pregnancy to lactation.
Akt overexpression has previously been implicated in the in-
duction of SREBP1c (Fleischmann and Iynedjian, 2000; Porst-
mann et al., 2005), a transcription factor that regulates the ex-
pression of several of the lipogenic enzymes that we found
were altered in Akt12/2 mice. Accordingly, quantitative RT-
PCR analysis of SREBP1a and SREBP1c expression levels
were performed using probes specific for each isoform (Porst-
mann et al., 2005). No difference in expression was detected
for either SREBP1 isoform between lactating Akt12/2 and
Akt1+/+mice or when Akt1 was transiently activated in themam-
mary glands ofMTB/tAkt1mice (Figures 7C and 7D). These find-
ings strongly suggest that Akt1-mediated regulation of lipogenic
enzymes in the lactating mammary gland is independent of
SREBP1.
Acly, the primary enzyme responsible for the synthesis of cy-
tosolic acetyl-CoA, is activated through phosphorylation by Akt
(Berwick et al., 2002). Acly hydrolyzes citrate produced in mito-
chondria and transported to the cytoplasm, thereby generating
oxaloacetate and acetyl-CoA, which serve as essential sub-
strates for NADPH generation and fatty-acid synthesis, respec-
tively. As predicted, immunoblotting performed for phospho-
Acly(Ser454) revealed that phospho-Acly levels were reduced
in the mammary glands of lactating Akt12/2 mice compared
to wild-type mice (Figure 7E). This indicates that loss of Akt1
results in decreased Acly activation in the mammary gland, sug-
gesting that impaired Acly activation may contribute to the
decreased synthesis of lipid observed in Akt12/2 mice.
In addition to the coordinate upregulation of lipid synthetic en-
zymes that normally occurs at the onset of lactation, coordinate
repression of enzymes involved in the b-oxidation of fatty acids
is also observed (Figure 7A). Presumably, such a shift would pre-
vent fatty acids from being catabolized by b-oxidation at the
same time that epithelial cells are synthesizing them for secre-
tion into milk. Notably, comparison of mammary expression
profiles of lactating Akt1+/+ and Akt12/2mice revealed the inap-
propriate derepression of multiple enzymes involved in the
b-oxidation of fatty acids (Figure 7F) that are otherwise
downregulated at the onset of lactation (Figure 7A). These in-
cluded several acyl-coenzyme A dehydrogenases (Acadm,
Acadl, and Acadvl), both subunits of the mitochondrial trifunc-
tional protein (Hadha and Hadhb), and Acaa2 (Figure 7F). These
observations indicate that Akt1 is required not only for the upre-
gulation of lipid synthetic enzymes that occurs at the transition
from pregnancy to lactation but also for the repression of en-
zymes involved in the b-oxidation of fatty acids. This, in turn,
suggests that Akt1 not only acts to promote the synthesis of
fatty acids during lactation but also concurrently suppresses
their catabolism.
Discussion
Nutritional support of offspring represents one of the most
critical and highly conserved functions found in mammals, so
much so that mammals are defined by their ability to produce485
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ithelial cells must coordinately upregulate pathways controlling
carbohydrate, protein, and lipid synthesis as well as the gener-
ation of an adequate supply of energy and reducing equivalents
to support these anabolic processes. In this manuscript, we
demonstrate that Akt1 is essential for this metabolic response.
The isoform-specific requirement that we have observed for
Akt1 in the developmental regulation of cellular metabolism in
the mammary gland is consistent with the upregulation of Akt1
expression that occurs during pregnancy and lactation. In con-
trast, Akt2 is dispensable for this developmental response to
metabolic stress. Notably, despite Akt1’s established role in the
regulation of cellular proliferation and apoptosis, the failure of
Akt12/2mice to lactate does not arise from a failure ofmammary
epithelial expansion during pregnancy or from structural defects
in the mammary gland. Rather, the developmental defects ob-
served in Akt1-deficient mice arise from a failure to coordinately
upregulate multiple metabolic pathways at the transition from
pregnancy to lactation. This suggests that the developmental
regulation of cellular metabolism represents a distinct facet of
the developmental program that results in secretory activation
and lactation in the mammary gland. Moreover, the failure of
Akt1-deficient mice to lactate demonstrates that these coordi-
nated metabolic changes are no less essential for the develop-
ment of the mammary gland than the structural changes that
occur in the gland during lobuloalveolar development.
The transition from pregnancy to lactation in the mammary
gland is normally accompanied by a coordinated gene expres-
sion program that promotes net lipogenesis by upregulating
lipid synthesis while downregulating lipid catabolism. This de-
velopmental program is disrupted by the loss of Akt1, thereby
leading to a defect in lactation. Specifically, loss of Akt1 at this
developmental transition results in a failure to upregulate glu-
cose uptake and trapping, a failure to upregulate Glut1, a failure
to localize Glut1 to the cell surface, a failure to upregulate lipid
synthesis, and a failure to upregulate the expression and activa-
tion of multiple lipogenic enzymes, including Acly, stearoyl-CoA
desaturase 2, and stearoyl-CoA desaturase 3. In addition, the
repression of enzymes involved in the b-oxidation of fatty acids
that normally occurs at the onset of lactation fails to occur in the
absence of Akt1. In aggregate, our findings indicate that Akt1 is
required for orchestrating the metabolic response of mammary
epithelial cells to the nutritional stress of lactation.
In vitro studies have implicated the PI3K/Akt pathway in reg-
ulating glucose transporter expression and localization in a vari-
ety of cell types and in response to multiple signals (reviewed in
Plas and Thompson, 2005; Welsh et al., 2005). Previously, the
requirement for Akt family members in glucose metabolism
had been ascribed almost exclusively to Akt2 (Cho et al.,
2001a; Garofalo et al., 2003). In contrast, our studies demon-
strate that Akt1 is absolutely required—and that Akt2 is entirely
dispensable—for translocation of Glut1 to the cell surface and
upregulation of glucose uptake and trapping at the onset of lac-
tation in the mammary gland. As such, these current findings
identify a developmental-stage-specific function for Akt1 and
reveal a requirement for Akt1 in the regulation of glucosemetab-
olism in vivo.Moreover, these effects are isoform specific, as the
upregulation of Glut1 and glucose uptake that accompanies lac-
tation occurs normally in mice lacking Akt2.
Once taken up by the lactating mammary epithelial cell, glu-
cose is either used in the synthesis of lactose or processed by486glycolysis to provide energy, reducing equivalents, and carbon
subunits for synthetic pathways. The data presented in this
manuscript indicate that upregulation of lipid synthesis—the
most abundant component of milk—is severely impaired in the
absence of Akt1. Our findings are consistent with overexpres-
sion studies implicating Akt1 in the control of lipogenesis (Gag-
non et al., 1999; Magun et al., 1996; Porstmann et al., 2005;
Schwertfeger et al., 2003) and extend these findings by demon-
strating that Akt1 is required for lipid synthesis in a physiologi-
cally relevant context.
In lipogenic cells with high rates of glucose uptake, mitochon-
dria produce citrate from glycolytically derived pyruvate by
means of a truncated TCA cycle (Baggetto, 1992). Citrate is
then preferentially exported to the cytosol via the tricarboxylate
transporter (Kaplan et al., 1993) and cleaved by Acly to form ox-
aloacetate and acetyl-CoA (Srere, 1959), the requisite building
block for de novo fatty-acid synthesis. Loss of Akt1 in lactating
mammary epithelial cells not only reduces the supply of carbon
units through decreased glucose uptake but also results in the
reduced phosphorylation and activation of Acly, thereby further
impairing fatty-acid synthesis. These data, along with recent
evidence demonstrating that knockdown of Acly activity impairs
Akt1-mediated leukemogenesis, suggest that Acly is an impor-
tant mediator of Akt activity in vivo (Bauer et al., 2005).
Loss of Akt1 also resulted in decreased expression of Scd2
and Scd3 in the lactating mammary gland. These enzymes cat-
alyze the conversion of saturated fatty acids to monounsatu-
rated fatty acids during the final phases of fatty-acid synthesis
and are normally upregulated at the onset of lactation (Miyazaki
and Ntambi, 2003). Consistent with a role for the diminished up-
regulation of Scd2 and Scd3 in impaired lipid synthesis in lac-
tating Akt12/2 mice, targeted deletion of Scd2 in mice reduces
triglyceride synthesis, and targeted deletion of Scd1 results in
decreased triglyceride synthesis and body adiposity as well
as increased hepatic expression of enzymes involved in the
b-oxidation of fatty acids (Miyazaki et al., 2005; Ntambi et al.,
2002). When taken together with the rapid induction of Scd2
andScd3 expression that we observe in vivo following activation
of Akt1, our findings identify these steroyl-CoA desaturases as
likely transcriptional targets of Akt1.
In addition to the failed upregulation of lipid synthetic
enzymes, multiple enzymes regulating mitochondrial b-oxida-
tion—which are normally repressed during lactation—were
inappropriately derepressed in the mammary glands of Akt12/2
mice. It can be speculated that, were such alterations to result
in increased fatty-acid oxidation, they would further contribute
to the decreased net synthesis of lipids observed in mammary
epithelial cells lacking Akt1.
Beyond the reduced lipid content of the lactating mammary
gland in Akt1-deficient mice, the absolute quantities of milk pro-
teins and lactose produced during lactation were also reduced
by loss of Akt1 as a consequence of the marked decrease in
milk volume. Potentially, this could reflect specific effects of
Akt1 on glucose uptake, which is required for the synthesis of
lactose and nonessential amino acids. Nevertheless, steady-
state levels of lactose and milk proteins were grossly normal
within lactating mammary epithelial cells of Akt12/2 mice,
whereas steady-state lipid levels were markedly reduced. The
predominance of the lipid synthetic defect observed in lactating
Akt12/2 mice may reflect the fact that lipid represents the chief
component of milk by weight, more than twice that of proteinCELL METABOLISM : DECEMBER 2006
Akt1 regulates metabolism during developmentand ten times that of lactose, and likely constitutes the principal
metabolic stress for lactating mammary epithelial cells. Since
Akt12/2 mice produce only a fraction of the milk produced by
their wild-type counterparts, potential defects in metabolic
pathways required for the synthesis of milk components other
than lipid may be masked. As such, given the marked reduction
in glucose uptake and trapping engendered by Akt1 loss, it is
possible that protein and lactose synthesis would be further
impaired were Akt12/2 mice able to generate normal quantities
of milk.
Interestingly, unlike mammary epithelial cells in lactating
Akt12/2mice, which have a reduced lipid content, the milk gen-
erated by Akt12/2 mice is normal in composition, though re-
duced in volume. This observation raises the intriguing possibil-
ity that a metabolic feedback mechanism may exist coupling
lipid synthesis to protein and lactose synthesis in the lactating
mammary gland in order to maintain the lipid content of milk
above a threshold level. If this is the case, however, such
a mechanism would likely be specific for lipid since mice homo-
zygous for targeted deletions of a-lactalbumin produce milk
that is devoid of lactose but rich in fat and protein (Stinnakre
et al., 1994) and mice homozygous for targeted deletions of
b-casein produce milk with reduced protein concentration (Ku-
mar et al., 1994). Nevertheless, while a specific mechanism by
which a defect in lipid synthesis might regulate the synthesis
or secretion of other macromolecules has yet to be elucidated,
given the physiological complexity of the lactating mammary
gland, systems biology considerations alone suggest that feed-
back loops interconnecting diverse metabolic pathways are
likely to exist.
To date, few isoform-specific functions for Akt1 and Akt2 have
been identified, and differing phenotypes inmice deficient for in-
dividual Akt family members have typically been attributed to
tissue-specific differences in the expression of different iso-
forms. One notable exception has been the ability of Akt family
members to regulate glucose uptake and metabolism, which
has previously been ascribed almost exclusively to Akt2. In-
deed, among the three Akt family members, only deletion of
Akt2 has thus far been shown to result in impaired metabolism
in mice. Consistent with this, siRNA-mediated knockdown of
Akt2—but not Akt1—in 3T3-L1 cells results in impaired glucose
uptake (Jiang et al., 2003). Similarly, reintroduction of Akt2—but
not Akt1—into Akt2-deficient adipocytes restores insulin-
induced glucose uptake (Bae et al., 2003).
In contrast, our studies demonstrate that Akt1 is absolutely re-
quired—and that Akt2 is entirely dispensable—for the develop-
mental-stage-specific upregulation and translocation of Glut1 to
the cell surface and for the upregulation of glucose uptake and
trapping. In addition, deletion of Akt1 causes a lipid synthetic
defect in the lactating mammary gland that is severe enough
to result in growth defects and pup mortality, whereas mice
lacking Akt2 lactate normally and support their young. As
such, the identification of this unexpected metabolic phenotype
in Akt1-deficient mice reveals a developmental-stage-specific
function for Akt1 and—contrary to prior expectations—clearly
establishes a role for Akt1 in glucose metabolism in vivo. Addi-
tionally, the expression of both Akt1 and Akt2 within the epithe-
lium and stroma of the mammary gland suggests that the pres-
ence of a lactation defect in Akt12/2, but not Akt22/2, mice
results from the loss of isoform-specific activities of Akt1 rather
than differences in the localization of Akt isoforms in the mam-CELL METABOLISM : DECEMBER 2006mary gland. As such, our data demonstrate that Akt1 acts as
a central metabolic regulator in the mammary gland during lac-
tation and suggest that its ability to do somay be due to isoform-
specifc functions of this Akt family member.
Finally, it is worth noting that the metabolic demands of the
lactating mammary epithelial cell bear many similarities to those
of tumor cells in that pathways controlling energy generation as
well as carbohydrate, protein, and lipid synthesis must be coor-
dinated to support the anabolic processes central to cell growth.
In this regard, Akt1’s ability to act as a central regulator of nutri-
ent uptake and utilization is consistent with the frequent obser-
vation of constitutive activation of the PI3K/AKT pathway in
a wide range of human cancers, including those of the breast
(Altomare and Testa, 2005). Transformed cells commonly ex-
hibit increased rates of glucose uptake as part of a shift to in-
creased glycolysis and reduced oxidative phosphorylation
(Warburg et al., 1924). Increased glycolytic metabolism in tu-
mors as determined by FDG-PET is associated with increased
tumor aggressiveness and poor prognosis (Buck et al., 2004;
Detterbeck et al., 2004). Beyond promoting cell survival through
maintenance of mitochondrial potential (Rathmell et al., 2003),
this adaptation facilitates the utilization of glucose in multiple
biosynthetic pathways required for cell growth, including the
synthesis of lipid for use in membranes (Bauer et al., 2004,
2005). Our findings demonstrating a physiological requirement
for Akt1 in the control of glucose and lipid metabolism further
implicate Akt1 activation as a potential mediator of the Warburg
effect and reinforce the importance of efforts to design pharma-
cologic agents that will inhibit this pathway in tumors.
Experimental procedures
Animals and milk collection
Akt12/2 (Cho et al., 2001b) and Akt22/2 (Cho et al., 2001a) mice were
backcrossed a minimum of ten generations onto a C57BL/6 background.
Bitransgenic mice that inducibly express Akt1 were generated by crossing
MMTV-rtTA (MTB) mice (Gunther et al., 2002) to TetO-Akt1 mice bearing
a myristoylated Akt1 allele fused to a tetracycline-inducible minimal pro-
moter. Transgenic animals were administered doxycycline (2 mg/ml; Sigma)
in their drinking water.
For milk collection, pups were removed for 3 hr at day 9 of lactation and
dams were injected with 10 units of oxytocin to induce milk letdown. Milk
wasmanually removed from the number threemammary glands. For analysis
of fat content, whole milk was centrifuged in capillary tubes as described
(Schwertfeger et al., 2003).
RNA analysis
RNA isolation and northern hybridization were performed as described, as
was preparation of biotinylated cRNA, hybridization to MGU74Av2 and
MOE430A Affymetrix arrays, and analysis using GeneChip MAS 5.0 (Master
et al., 2002). Microarray data have been deposited inMIAMEXPRESS (acces-
sion numbers E-MEXP-891 and E-MEXP-892). Northern blots were quanti-
fied using a Molecular Dynamics phosphorimager.
Quantitative RT-PCR using TaqMan assays (Applied Biosystems) were
performed using an ABI Prism sequence detection system (Applied Biosys-
tems). Probes used were as follows: Acly, assay ID Mm00652520_m1;
Acacb, assay ID Mm01204657_m1; Fasn, assay ID Mm00662319_m1;
Scd1, assay ID Mm00772290_m1; Scd2, Assay ID Mm00485951_g1;
Scd3, assay ID Mm00470480_m1; Dgat2, assay ID Mm00499530_m1;
Tbp, assay ID Mm00446973_m1; Srebp1a and Srebp1c (Shimomura et al.,
1997). Gene expression levels were normalized to Tbp.
Epithelial and adipose tissue isolation
Mammary tissues wereminced and digested in a collagenase solution (1mg/
ml collagenase, 1 mg/ml fatty-acid-free BSA in EBSS) for 3 hr at 37C using487
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to the bottom of the tube for 15 min, the collagenase solution was replaced,
and the incubation was continued for an additional hour. After pelleting at
1000 rpm for 4 min, epithelial cells were washed three times and lysed in
sample loading buffer. Adipose tissue was treated identically except for
the omission of collagenase from the digestion medium.
Quantification of epithelial nuclei and alveoli
Epithelial nuclei and alveoli were quantified onmammary sections from day 9
lactating mice stained for CK8 primary antibody with Hoechst 33258 nuclear
counterstaining. Five images per animal and three animals per genotype
were captured for analysis. Cell counts were obtained using ImagePro Plus
5.0 (Media Cybernetics).
Western analysis
Western blotting was performed as described (Gardner et al., 2000) with the
following antibodies: phospho-Akt(Ser473), Akt, Akt1 (2H10), Akt2 (5B5),
phospho-Acly(Ser454), Acly, phospho-S6(Ser235/236), and S6 (Cell Signal-
ing); b-tubulin (clone DM-1, InnoGenex); and actin (Santa Cruz). Membranes
for milk protein western blots were blocked in 3% BSA, 13 PBS, and 0.05%
Tween 20 (PBST-BSA) and probed with polyclonal rabbit antisera to mouse
milk-specific proteins (Nordic Immunological Laboratories).
Fluorescence and immunofluorescence
Ten micrometer mammary sections embedded in OCTmedium were fixed in
acetone (NKCC1, Npt2b) or 4% PFA for 10 min (casein, Glut1, CK8) at room
temperature. Primary antibodies were incubated on sections overnight at
4C using the rabbit polyclonal antibodies NKCC1 (1:1,000, gift from Dr.
Jim Turner, NIDCR), Npt2b (1:300, gift from Dr. Jurg Biber, University of Zur-
ich), and Glut1 (1:5,000, Dr. Morris Birnbaum, University of Pennsylvania) or
the monoclonal antibodies rat anti-E-cadherin (1:100; Zymed), mouse anti-
smooth muscle actin (1:400, Sigma), and cytokeratin 8 (1:100, Developmen-
tal Studies Hybridoma Bank, University of Iowa) or anti-casein (clone RB4,
gift from Dr. Mina Bissell, Lawrence Berkeley National Laboratory). Following
incubation with appropriate Alexa 488 and Alexa 568 (Molecular Probes) fluo-
rescent-conjugated secondary antibodies (1:1,000), sections were counter-
stained with Hoechst 33258 (1:10,000) and mounted with Fluoromount-G
(Southern Biotechnology Associates).
Lipid and lactose staining were performed on 10 mmOCT-embedded sec-
tions fixed in 4% PFA. For lipids, sections were stained with Hoechst 33258
and coverslipped with a drop of Nile red solution (1:200 dilution in 75% glyc-
erol). For lactose, following CK8 antibody and Alexa 488 incubation, sections
were stained with Texas red-labeled ECA lectin (EY laboratories) and
Hoechst 33258 and coverslipped with Fluoromount-G.
Electron microscopy
Minced tissues were fixed in 2.5% glutaraldehyde and 4% PFA and post-
fixed with 2% osmium tetroxide (OsO4) in 0.1 M sodium cacodylate (pH
7.2). After embedding in Polybed resin (Polysciences, Inc.), 60–70 nm sec-
tions were placed on 200-mesh copper grids and stained with 1% uranyl
acetate in 50% ethanol and bismuth subnitrate (1:50). Images were
viewed and captured using a JEOL 1010 transmission electron mi-
croscope equipped with a Hamamatsu CCD camera and AMT imaging
software.
FDG-PET imaging
Mice were administered [18F]FDG (0.4–0.6 mCi) via tail-vein injection 2 hr
prior to PET scanning. Mice were anesthetized via inhalation with isofluorane
immediately prior to and during scanning. PET scanning and image process-
ing were performed as described (Surti et al., 2005).
Acknowledgments
This research was supported in part by National Cancer Institute grants
CA92910, CA93719, CA98371, and CA105490 and US Army Breast Cancer
Research Program grants W81XWH-05-1-0405, DAMD17-00-1-0397
(R.B.B.), and DAMD17-98-1-8235 (D.B.S.). Special thanks to Alexander
Stoddard for assistance with figure preparation.488Received: April 26, 2006
Revised: August 11, 2006
Accepted: October 27, 2006
Published: December 5, 2006
References
Altomare, D.A., and Testa, J.R. (2005). Perturbations of the AKT signaling
pathway in human cancer. Oncogene 24, 7455–7464.
Bae, S.S., Han, C., Mu, J., and Birnbaum, M.J. (2003). Isoform-specific reg-
ulation of insulin-dependent glucose uptake by Akt/PKB. J. Biol. Chem. 278,
49530–49536.
Baggetto, L.G. (1992). Deviant energetic metabolism of glycolytic cancer
cells. Biochimie 74, 959–974.
Barber, M.C., Clegg, R.A., Travers, M.T., and Vernon, R.G. (1997). Lipid me-
tabolism in the lactating mammary gland. Biochim. Biophys. Acta 1347, 101–
126.
Barnes, K., McIntosh, E., Whetton, A.D., Daley, G.Q., Bentley, J., and Bald-
win, S.A. (2005). Chronic myeloid leukaemia: an investigation into the role of
Bcr-Abl-induced abnormalities in glucose transport regulation. Oncogene
24, 3257–3267.
Bauer, D.E., Harris, M.H., Plas, D.R., Lum, J.J., Hammerman, P.S., Rathmell,
J.C., Riley, J.L., and Thompson, C.B. (2004). Cytokine stimulation of aerobic
glycolysis in hematopoietic cells exceeds proliferative demand. FASEB J. 18,
1303–1305.
Bauer, D.E., Hatzivassiliou, G., Zhao, F., Andreadis, C., and Thompson, C.B.
(2005). ATP citrate lyase is an important component of cell growth and trans-
formation. Oncogene 24, 6314–6322.
Berwick, D.C., Hers, I., Heesom, K.J., Moule, S.K., and Tavare, J.M. (2002).
The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in
primary adipocytes. J. Biol. Chem. 277, 33895–33900.
Borst, D.W., and Mahoney, W.B. (1982). Mouse mammary gland DNA syn-
thesis during pregnancy. J. Exp. Zool. 221, 245–250.
Buck, A.K., Schirrmeister, H., Mattfeldt, T., and Reske, S.N. (2004). Biological
characterisation of breast cancer by means of PET. Eur. J. Nucl. Med. Mol.
Imaging 31 (Suppl 1), S80–S87.
Camps, M., Vilaro, S., Testar, X., Palacin, M., and Zorzano, A. (1994). High
and polarized expression of GLUT1 glucose transporters in epithelial cells
frommammary gland: acute down-regulation of GLUT1 carriers by weaning.
Endocrinology 134, 924–934.
Chen, J., De, S., Damron, D.S., Chen, W.S., Hay, N., and Byzova, T.V. (2004).
Impaired platelet responses to thrombin and collagen in AKT-1-deficient
mice. Blood 104, 1703–1710.
Chen, W.S., Xu, P.Z., Gottlob, K., Chen, M.L., Sokol, K., Shiyanova, T., Ro-
ninson, I., Weng, W., Suzuki, R., Tobe, K., et al. (2001). Growth retardation
and increased apoptosis in mice with homozygous disruption of the Akt1
gene. Genes Dev. 15, 2203–2208.
Cho, H., Mu, J., Kim, J.K., Thorvaldsen, J.L., Chu, Q., Crenshaw, E.B., III,
Kaestner, K.H., Bartolomei, M.S., Shulman, G.I., and Birnbaum, M.J.
(2001a). Insulin resistance and a diabetes mellitus-like syndrome in mice
lacking the protein kinase Akt2 (PKB beta). Science 292, 1728–1731.
Cho, H., Thorvaldsen, J.L., Chu, Q., Feng, F., and Birnbaum, M.J. (2001b).
Akt1/PKBalpha is required for normal growth but dispensable for mainte-
nance of glucose homeostasis in mice. J. Biol. Chem. 276, 38349–38352.
Chodosh, L.A., Gardner, H.P., Rajan, J.V., Stairs, D.B., Marquis, S.T., and
Leder, P.A. (2000). Protein kinase expression during murine mammary devel-
opment. Dev. Biol. 219, 259–276.
Dan, H.C., Sun, M., Yang, L., Feldman, R.I., Sui, X.M., Ou, C.C., Nellist, M.,
Yeung, R.S., Halley, D.J., Nicosia, S.V., et al. (2002). Phosphatidylinositol
3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor com-
plex by phosphorylation of tuberin. J. Biol. Chem. 277, 35364–35370.CELL METABOLISM : DECEMBER 2006
Akt1 regulates metabolism during developmentDetterbeck, F.C., Vansteenkiste, J.F., Morris, D.E., Dooms, C.A., Khandani,
A.H., and Socinski, M.A. (2004). Seeking a home for a PET, part 3: Emerging
applications of positron emission tomography imaging in the management of
patients with lung cancer. Chest 126, 1656–1666.
Easton, R.M., Cho, H., Roovers, K., Shineman, D.W., Mizrahi, M., Forman,
M.S., Lee, V.M., Szabolcs, M., de Jong, R., Oltersdorf, T., et al. (2005).
Role for Akt3/protein kinase Bgamma in attainment of normal brain size.
Mol. Cell. Biol. 25, 1869–1878.
Fleischmann, M., and Iynedjian, P.B. (2000). Regulation of sterol regulatory-
element binding protein 1 gene expression in liver: role of insulin and protein
kinase B/cAkt. Biochem. J. 349, 13–17.
Gagnon, A., Chen, C.S., and Sorisky, A. (1999). Activation of protein kinase B
and induction of adipogenesis by insulin in 3T3-L1 preadipocytes: contribu-
tion of phosphoinositide-3,4,5-trisphosphate versus phosphoinositide-3,4-
bisphosphate. Diabetes 48, 691–698.
Gardner, H.P., Belka, G.K., Wertheim, G.B., Hartman, J.L., Ha, S.I., Gimotty,
P.A., Marquis, S.T., and Chodosh, L.A. (2000). Developmental role of the
SNF1-related kinase Hunk in pregnancy-induced changes in the mammary
gland. Development 127, 4493–4509.
Garofalo, R.S., Orena, S.J., Rafidi, K., Torchia, A.J., Stock, J.L., Hildebrandt,
A.L., Coskran, T., Black, S.C., Brees, D.J., Wicks, J.R., et al. (2003). Severe
diabetes, age-dependent loss of adipose tissue, and mild growth deficiency
in mice lacking Akt2/PKB beta. J. Clin. Invest. 112, 197–208.
Gottlob, K., Majewski, N., Kennedy, S., Kandel, E., Robey, R.B., and Hay, N.
(2001). Inhibition of early apoptotic events by Akt/PKB is dependent on the
first committed step of glycolysis and mitochondrial hexokinase. Genes
Dev. 15, 1406–1418.
Gunther, E.J., Belka, G.K., Wertheim, G.B., Wang, J., Hartman, J.L., Boxer,
R.B., and Chodosh, L.A. (2002). A novel doxycycline-inducible system for
the transgenic analysis of mammary gland biology. FASEB J. 16, 283–292.
Inoki, K., Li, Y., Zhu, T., Wu, J., and Guan, K.L. (2002). TSC2 is phosphory-
lated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol.
4, 648–657.
Jiang, Z.Y., Zhou, Q.L., Coleman, K.A., Chouinard,M., Boese, Q., andCzech,
M.P. (2003). Insulin signaling through Akt/protein kinase B analyzed by small
interfering RNA-mediated gene silencing. Proc. Natl. Acad. Sci. USA 100,
7569–7574.
Kaplan, R.S., Mayor, J.A., and Wood, D.O. (1993). The mitochondrial tricar-
boxylate transport protein. cDNA cloning, primary structure, and comparison
with other mitochondrial transport proteins. J. Biol. Chem. 268, 13682–
13690.
Kohn, A.D., Summers, S.A., Birnbaum, M.J., and Roth, R.A. (1996). Expres-
sion of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stim-
ulates glucose uptake and glucose transporter 4 translocation. J. Biol. Chem.
271, 31372–31378.
Kumar, S., Clarke, A.R., Hooper, M.L., Horne, D.S., Law, A.J., Leaver, J.,
Springbett, A., Stevenson, E., and Simons, J.P. (1994). Milk composition
and lactation of beta-casein-deficient mice. Proc. Natl. Acad. Sci. USA 91,
6138–6142.
Listenberger, L.L., Han, X., Lewis, S.E., Cases, S., Farese, R.V., Jr., Ory, D.S.,
and Schaffer, J.E. (2003). Triglyceride accumulation protects against fatty
acid-induced lipotoxicity. Proc. Natl. Acad. Sci. USA 100, 3077–3082.
Magun, R., Burgering, B.M., Coffer, P.J., Pardasani, D., Lin, Y., Chabot, J.,
and Sorisky, A. (1996). Expression of a constitutively activated form of protein
kinase B (c-Akt) in 3T3-L1 preadipose cells causes spontaneous differentia-
tion. Endocrinology 137, 3590–3593.
Manning, B.D., Tee, A.R., Logsdon, M.N., Blenis, J., and Cantley, L.C. (2002).
Identification of the tuberous sclerosis complex-2 tumor suppressor gene
product tuberin as a target of the phosphoinositide 3-kinase/akt pathway.
Mol. Cell 10, 151–162.
Master, S.R., Hartman, J.L., D’Cruz, C.M., Moody, S.E., Keiper, E.A., Ha, S.I.,
Cox, J.D., Belka, G.K., and Chodosh, L.A. (2002). Functional microarray anal-CELL METABOLISM : DECEMBER 2006ysis of mammary organogenesis reveals a developmental role in adaptive
thermogenesis. Mol. Endocrinol. 16, 1185–1203.
Master, S.R., Stoddard, A.J., Bailey, L.C., Pan, T.C., Dugan, K.D., and Cho-
dosh, L.A. (2005). Genomic analysis of early murine mammary gland devel-
opment using novel probe-level algorithms. Genome Biol. 6, R20.
Miyazaki, M., and Ntambi, J.M. (2003). Role of stearoyl-coenzyme A desatur-
ase in lipid metabolism. Prostaglandins Leukot. Essent. Fatty Acids 68, 113–
121.
Miyazaki, M., Dobrzyn, A., Elias, P.M., andNtambi, J.M. (2005). Stearoyl-CoA
desaturase-2 gene expression is required for lipid synthesis during early skin
and liver development. Proc. Natl. Acad. Sci. USA 102, 12501–12506.
Ntambi, J.M., Miyazaki, M., Stoehr, J.P., Lan, H., Kendziorski, C.M., Yandell,
B.S., Song, Y., Cohen, P., Friedman, J.M., and Attie, A.D. (2002). Loss of
stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc.
Natl. Acad. Sci. USA 99, 11482–11486.
Plas, D.R., and Thompson, C.B. (2005). Akt-dependent transformation: there
is more to growth than just surviving. Oncogene 24, 7435–7442.
Plas, D.R., Talapatra, S., Edinger, A.L., Rathmell, J.C., and Thompson, C.B.
(2001). Akt and Bcl-xL promote growth factor-independent survival through
distincteffectsonmitochondrial physiology.J.Biol.Chem.276, 12041–12048.
Porstmann, T., Griffiths, B., Chung, Y.L., Delpuech, O., Griffiths, J.R., Down-
ward, J., and Schulze, A. (2005). PKB/Akt induces transcription of enzymes
involved in cholesterol and fatty acid biosynthesis via activation of SREBP.
Oncogene 24, 6465–6481.
Potter, C.J., Pedraza, L.G., and Xu, T. (2002). Akt regulates growth by directly
phosphorylating Tsc2. Nat. Cell Biol. 4, 658–665.
Rathmell, J.C., Fox, C.J., Plas, D.R., Hammerman, P.S., Cinalli, R.M., and
Thompson, C.B. (2003). Akt-directed glucose metabolism can prevent Bax
conformation change and promote growth factor-independent survival.
Mol. Cell. Biol. 23, 7315–7328.
Rosen, J.M., Wyszomierski, S.L., and Hadsell, D. (1999). Regulation of milk
protein gene expression. Annu. Rev. Nutr. 19, 407–436.
Schwertfeger, K.L., Richert, M.M., and Anderson, S.M. (2001). Mammary
gland involution is delayed by activated Akt in transgenic mice. Mol. Endocri-
nol. 15, 867–881.
Schwertfeger, K.L., McManaman, J.L., Palmer, C.A., Neville, M.C., and
Anderson, S.M. (2003). Expression of constitutively activated Akt in the
mammary gland leads to excess lipid synthesis during pregnancy and lacta-
tion. J. Lipid Res. 44, 1100–1112.
Shillingford, J.M., Miyoshi, K., Robinson, G.W., Bierie, B., Cao, Y., Karin, M.,
and Hennighausen, L. (2003). Proteotyping of mammary tissue from trans-
genic and gene knockout mice with immunohistochemical markers: a tool
to define developmental lesions. J. Histochem. Cytochem. 51, 555–565.
Shimomura, I., Shimano, H., Horton, J.D., Goldstein, J.L., and Brown, M.S.
(1997). Differential expression of exons 1a and 1c in mRNAs for sterol regu-
latory element binding protein-1 in human and mouse organs and cultured
cells. J. Clin. Invest. 99, 838–845.
Singh, K., Hartley, D.G., McFadden, T.B., and Mackenzie, D.D. (2004). Die-
tary fat regulates mammary stearoyl coA desaturase expression and activity
in lactating mice. J. Dairy Res. 71, 1–6.
Srere, P.A. (1959). The citrate cleavage enzyme. I. Distribution and purifica-
tion. J. Biol. Chem. 234, 2544–2547.
Stinnakre, M.G., Vilotte, J.L., Soulier, S., and Mercier, J.C. (1994). Creation
and phenotypic analysis of alpha-lactalbumin-deficient mice. Proc. Natl.
Acad. Sci. USA 91, 6544–6548.
Surti, S., Karp, J.S., Perkins, A.E., Cardi, C.A., Daube-Witherspoon, M.E.,
Kuhn, A., andMuehllehner, G. (2005). Imaging performance of A-PET: a small
animal PET camera. IEEE Trans. Med. Imaging 24, 844–852.
Tschopp, O., Yang, Z.Z., Brodbeck, D., Dummler, B.A., Hemmings-Mieszc-
zak, M., Watanabe, T., Michaelis, T., Frahm, J., and Hemmings, B.A. (2005).
Essential role of protein kinase B gamma (PKB gamma/Akt3) in postnatal489
A R T I C L Ebrain development but not in glucose homeostasis. Development 132, 2943–
2954.
Van de Sande, T., De Schrijver, E., Heyns, W., Verhoeven, G., and Swinnen,
J.V. (2002). Role of the phosphatidylinositol 30-kinase/PTEN/Akt kinase path-
way in the overexpression of fatty acid synthase in LNCaP prostate cancer
cells. Cancer Res. 62, 642–646.
Warburg, O., Posener, K., and Negelein, E. (1924). Uber den stoffwechsel der
tumoren. Biochem. Z. 152, 319–344.490Welsh, G.I., Hers, I., Berwick, D.C., Dell, G., Wherlock, M., Birkin, R., Leney,
S., and Tavare, J.M. (2005). Role of protein kinase B in insulin-regulated glu-
cose uptake. Biochem. Soc. Trans. 33, 346–349.
Accession numbers
Microarray data have been deposited in MIAMEXPRESS with the accession
numbers E-MEXP-891 and E-MEXP-892.CELL METABOLISM : DECEMBER 2006
